Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bisoxatin Diacetate
1. 14008-48-1
2. Wy 8138
3. Wy-8138
4. 79w5lfs83k
5. Laxonalin
6. Maratan
7. 2,2-bis(p-hydroxyphenyl)-2h-1,4-benzoxazin-3(4h)-one Diacetate
8. 2h-1,4-benzoxazin-3(4h)-one, 2,2-bis(4-(acetyloxy)phenyl)-
9. Ncgc00182998-01
10. Metrolax
11. Wylaxine
12. Talsis
13. Tasis
14. Kritel Tropfen
15. (3-oxo-3,4-dihydro-2h-benzo[b][1,4]oxazine-2,2-diyl)bis(4,1-phenylene) Diacetate
16. Bisoxatin Acetate [usan:jan]
17. Einecs 237-820-5
18. Brn 0589169
19. Unii-79w5lfs83k
20. 2,2-bis(4-acetoxyphenyl)-2h-1,4-benzoxazin-3(4h)-one
21. 2,2-bis(4-acetoxyphenyl)-3-oxo-2,3-dihydrobenz-1,4-oxazine
22. 2h-1,4-benzoazin-3(4h)-one, 2,2-bis(4-(acetoxy)phenyl)-
23. 2,2-bis(p-hydroxyphenyl)-2h-1,4-benzoazin-3(4h)-one Diacetate
24. 2,2-bis(4-(acetyloxy)phenyl)-2h-1,4-benzoxazin-3(4h)-one Diacetate
25. [4-[2-(4-acetyloxyphenyl)-3-oxo-4h-1,4-benzoxazin-2-yl]phenyl] Acetate
26. Dsstox_cid_28765
27. Dsstox_rid_83034
28. Dsstox_gsid_48839
29. Schembl364629
30. Bisoxatin Acetate [mi]
31. Bisoxatin Acetate (jan/usan)
32. Bisoxatin Acetate [jan]
33. Bisoxatin Acetate [usan]
34. Chembl2106004
35. Dtxsid1048839
36. Chebi:31294
37. Bisoxatin Acetate [mart.]
38. Zinc608211
39. Bisoxatin Acetate [who-dd]
40. Bcp31468
41. Tox21_113321
42. 2h-1,4-benzoxazin-3-(4h)-one, 2,2-bis(p-hydroxyphenyl)-, Diacetate
43. Db14654
44. Cas-14008-48-1
45. Ft-0724909
46. D01191
47. Q27266785
48. 4,4'-(3-oxo-3,4-dihydro-2h-benzo[b][1,4]oxazine-2,2-diyl)bis(4,1-phenylene) Diacetate
| Molecular Weight | 417.4 g/mol |
|---|---|
| Molecular Formula | C24H19NO6 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 417.12123733 g/mol |
| Monoisotopic Mass | 417.12123733 g/mol |
| Topological Polar Surface Area | 90.9 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 642 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Bisoxatin acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bisoxatin acetate, including repackagers and relabelers. The FDA regulates Bisoxatin acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bisoxatin acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bisoxatin acetate supplier is an individual or a company that provides Bisoxatin acetate active pharmaceutical ingredient (API) or Bisoxatin acetate finished formulations upon request. The Bisoxatin acetate suppliers may include Bisoxatin acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Bisoxatin acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bisoxatin acetate written confirmation (Bisoxatin acetate WC) is an official document issued by a regulatory agency to a Bisoxatin acetate manufacturer, verifying that the manufacturing facility of a Bisoxatin acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bisoxatin acetate APIs or Bisoxatin acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Bisoxatin acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Bisoxatin acetate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bisoxatin acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bisoxatin acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bisoxatin acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bisoxatin acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bisoxatin acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bisoxatin acetate suppliers with NDC on PharmaCompass.
Bisoxatin acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bisoxatin acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bisoxatin acetate GMP manufacturer or Bisoxatin acetate GMP API supplier for your needs.
A Bisoxatin acetate CoA (Certificate of Analysis) is a formal document that attests to Bisoxatin acetate's compliance with Bisoxatin acetate specifications and serves as a tool for batch-level quality control.
Bisoxatin acetate CoA mostly includes findings from lab analyses of a specific batch. For each Bisoxatin acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bisoxatin acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bisoxatin acetate EP), Bisoxatin acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bisoxatin acetate USP).
LOOKING FOR A SUPPLIER?
